Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine

被引:27
作者
Manner, Hendrik [1 ]
Jung, Bernd [2 ]
Tonassi, Leonhard [2 ]
Hackenberg, Ulrich [2 ]
Plum, Nicola [1 ]
Josten, Klaus M.
Kirchmaier, Carl M. [3 ]
Frickhofen, Norbert [2 ]
机构
[1] Johannes Gutenberg Univ Mainz, Teaching Hosp, HSK Wiesbaden, Klin Innere Med 2,Dept Internal Med 2, D-65199 Wiesbaden, Germany
[2] Johannes Gutenberg Univ Mainz, Teaching Hosp, HSK Wiesbaden, Dept Internal Med 3, D-65199 Wiesbaden, Germany
[3] Deutsch Klin Diagnost, Haemostat Unit, D-6200 Wiesbaden, Germany
关键词
catastrophic antiphospholipid antibody syndrome; low-molecular weight heparin; rituximab; bendamustine;
D O I
10.1097/MAJ.0b013e31815203ad
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Case report A 69-year-old woman with splenic marginal-zone lymphoma was admitted with progressive abdominal pain and splenomegaly as the suspected cause of pain. Rituximab treatment (375 mg/m(2)) had been initiated on the day of admission. Abdominal computerized tomography revealed splenic infarction. Laboratory tests showed elevation of liver enzymes and creatinine, low platelet count, prolonged partial thromboplastin time, and lupus anticoagulant positivity. The diagnosis of catastrophic antiphospholipid antibody syndrome was made. Weight-adjusted low-molecular weight heparin therapy was initiated. Freedom from symptoms and normalization of liver enzymes and creatinine occurred within 4 weeks. Treatment was continued with 6 cycles of bendamustine monotherapy (90 mg/m(2)) and heparin, leading to partial remission of lymphoma and lupus anticoagulant negativity. Conclusions: In case of multiorgan failure in patients suffering from lymphoma and showing features of disseminated intravascular coagulation, catastrophic antiphospholipid antibody syndrome should be considered. In our patient, rituximab followed by weight-adjusted low-molecular weight heparin and bendamustine therapy led to recovery.
引用
收藏
页码:394 / 397
页数:4
相关论文
共 11 条
[1]   Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome [J].
Asherson, RA .
IMMUNOBIOLOGY, 2005, 210 (10) :727-733
[2]   Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome:: clinical and haematological characteristics of 23 patients [J].
Asherson, RA ;
Espinosa, G ;
Cervera, R ;
Gómez-Puerta, JA ;
Musuruana, J ;
Bucciarelli, S ;
Ramos-Casal, M ;
Martínez-González, AL ;
Ingelmo, M ;
Reverter, JC ;
Font, J ;
Triplett, DA .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) :943-946
[3]  
ASHERSON RA, 1992, J RHEUMATOL, V19, P508
[4]   CASE REPORT: Hepatic involvement in antiphospholipid syndrome [J].
Barak, N ;
Orion, Y ;
Schneider, M ;
Bernheim, J ;
Mekori, YA .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (11) :1124-1128
[5]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027
[6]   Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome [J].
Cervera, R ;
Font, J ;
Gómez-Puerta, JA ;
Espinosa, G ;
Cucho, M ;
Bucciarelli, S ;
Ramos-Casals, M ;
Ingelmo, M ;
Piette, JC ;
Shoenfeld, Y ;
Asherson, RA .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1205-1209
[7]   Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy [J].
Dentali, F ;
Manfredi, E ;
Crowther, M ;
Ageno, W .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (09) :2121-2123
[8]  
EHRESMANN S, 2004, ANN RHEUM S1, V64
[9]  
PIETTE JC, 1994, SEMIN ARTHRITIS RHEU, V23, P367
[10]   Antiphospholipid antibodies in lymphoma: prevalence and clinical significance [J].
Pusterla, S ;
Previtali, S ;
Marziali, S ;
Cortelazzo, S ;
Rossi, A ;
Barbui, T ;
Galli, M .
HEMATOLOGY JOURNAL, 2004, 5 (04) :341-346